{
  "LIXT": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-10T22:14:12Z",
      "headline": "LIXTE Biotechnology Submits Request For Withdrawal Of Form S-1 Registration Statement; No Longer Intends To Pursue Public Offering AT This Time",
      "id": 43610428,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "LIXT"
      ],
      "updated_at": "2025-02-10T22:14:13Z",
      "url": "https://www.benzinga.com/news/25/02/43610428/lixte-biotechnology-submits-request-for-withdrawal-of-form-s-1-registration-statement-no-longer-inte",
      "added_at": "2025-02-11T09:20:48.882Z"
    },
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-11T13:44:54Z",
      "headline": "LIXTE Announces Purchase And Sale Of 434,784 Shares At $2.415 Each In Registered Direct Offering With Proceeds Expected To Be ~$1.05M",
      "id": 43622718,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "LIXT"
      ],
      "updated_at": "2025-02-11T13:44:55Z",
      "url": "https://www.benzinga.com/news/25/02/43622718/lixte-announces-purchase-and-sale-of-434-784-shares-at-2-415-each-in-registered-direct-offering-with",
      "added_at": "2025-02-11T13:45:17.762Z"
    }
  ],
  "SLQT": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-10T21:08:22Z",
      "headline": "SelectQuote Announces $350M Strategic Investment From Bain Capital, Morgan Stanley Private Credit And Newlight Partners Positioning The Co To Continue Growing Its Healthcare Services Business, Deepening Its Relationship With Carrier Partners And Providing Choice And Value For Consumers",
      "id": 43608191,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "SLQT"
      ],
      "updated_at": "2025-02-10T21:08:23Z",
      "url": "https://www.benzinga.com/news/25/02/43608191/selectquote-announces-350m-strategic-investment-from-bain-capital-morgan-stanley-private-credit-and",
      "added_at": "2025-02-11T09:20:48.882Z"
    },
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-10T21:07:29Z",
      "headline": "SelectQuote Sees FY25 Revenue Forecast $1.5B-$1.575B Vs $1.46B Est., Net Income (Loss) Projected $(24)M-$11M, Adjusted EBITDA Expected $115M-$140M",
      "id": 43608136,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "SLQT"
      ],
      "updated_at": "2025-02-10T21:07:29Z",
      "url": "https://www.benzinga.com/news/25/02/43608136/selectquote-sees-fy25-revenue-forecast-1-5b-1-575b-vs-1-46b-est-net-income-loss-projected-24-m-11m-a",
      "added_at": "2025-02-11T09:20:48.882Z"
    },
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-10T21:05:57Z",
      "headline": "SelectQuote Q2 EPS $0.30 Beats $0.10 Estimate, Sales $481.07M Beat $447.00M Estimate",
      "id": 43607999,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "SLQT"
      ],
      "updated_at": "2025-02-10T21:05:57Z",
      "url": "https://www.benzinga.com/news/earnings/25/02/43607999/selectquote-q2-eps-0-30-beats-0-10-estimate-sales-481-07m-beat-447-00m-estimate",
      "added_at": "2025-02-11T09:20:48.882Z"
    }
  ],
  "LIPO": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-11T10:49:42Z",
      "headline": "Lipella Pharmaceuticals Shares Phase 2a Results For LP-310 In The Treatment Of Oral Lichen Planus, Showing Favorable Safety Profile And Tolerability Of Twice-Daily Oral Rinse",
      "id": 43617270,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "LIPO"
      ],
      "updated_at": "2025-02-11T10:49:42Z",
      "url": "https://www.benzinga.com/general/health-care/25/02/43617270/lipella-pharmaceuticals-shares-phase-2a-results-for-lp-310-in-the-treatment-of-oral-lichen-pl",
      "added_at": "2025-02-11T10:50:14.471Z"
    },
    {
      "author": "Vandana Singh",
      "content": "",
      "created_at": "2025-02-11T15:52:36Z",
      "headline": "Nano Cap Lipella Pharmaceuticals Stock Jumps On Positive Trial Data In Patients With Sore Mouth Membranes",
      "id": 43629227,
      "images": [
        {
          "size": "large",
          "url": "https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2025/02/11/LIPO.png"
        },
        {
          "size": "small",
          "url": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2025/02/11/LIPO.png"
        },
        {
          "size": "thumb",
          "url": "https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2025/02/11/LIPO.png"
        }
      ],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "LIPO"
      ],
      "updated_at": "2025-02-11T15:52:36Z",
      "url": "https://www.benzinga.com/25/02/43629227/nano-cap-lipella-pharmaceuticals-stock-jumps-on-positive-trial-data-in-patients-with-sore-mouth-membranes",
      "added_at": "2025-02-11T15:55:20.690Z"
    }
  ],
  "KPRX": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-11T11:49:29Z",
      "headline": "Kiora Gets Approval To Begin KLARITY, A Phase 2 Clinical Trial To Investigate KIO-104 In Patients With Retinal Macular Edem",
      "id": 43618550,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "KPRX"
      ],
      "updated_at": "2025-02-11T11:49:29Z",
      "url": "https://www.benzinga.com/general/health-care/25/02/43618550/kiora-gets-approval-to-begin-klarity-a-phase-2-clinical-trial-to-investigate-kio-104-in-patie",
      "added_at": "2025-02-11T11:50:15.518Z"
    }
  ],
  "DGHI": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-11T12:34:37Z",
      "headline": "Digihost Forms Wholly-Owned Subsidiary, US Data Centers To Develop High-Performance Computing And AI-Tier Data Centers",
      "id": 43619940,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "DGHI"
      ],
      "updated_at": "2025-02-11T12:34:37Z",
      "url": "https://www.benzinga.com/news/25/02/43619940/digihost-forms-wholly-owned-subsidiary-us-data-centers-to-develop-high-performance-computing-and-ai",
      "added_at": "2025-02-11T12:35:16.493Z"
    }
  ],
  "SILO": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-11T12:47:14Z",
      "headline": "Silo Pharma's SP-26 Implant Shows Early Results in Chronic Pain and Fibromyalgia Study",
      "id": 43620286,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "SILO"
      ],
      "updated_at": "2025-02-11T12:47:14Z",
      "url": "https://www.benzinga.com/news/25/02/43620286/silo-pharmas-sp-26-implant-shows-early-results-in-chronic-pain-and-fibromyalgia-study",
      "added_at": "2025-02-11T12:50:16.634Z"
    }
  ],
  "ACON": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-11T12:59:56Z",
      "headline": "Aclarion Secures 24th US Patent, Expanding Use of Biomarkers to Detect Pain and Infections Across the Body",
      "id": 43620655,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "ACON"
      ],
      "updated_at": "2025-02-11T12:59:56Z",
      "url": "https://www.benzinga.com/government/25/02/43620655/aclarion-secures-24th-us-patent-expanding-use-of-biomarkers-to-detect-pain-and-infections-across-the",
      "added_at": "2025-02-11T13:00:17.009Z"
    }
  ],
  "TRNR": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-11T13:11:57Z",
      "headline": "Interactive Strength To Acquire Sportstech Holding; To Acquire 99% Of Sportstech In All-Stock Transaction With Initial Consideration Of $15M In Non-Voting Convertible Preferred Stock",
      "id": 43621307,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "TRNR"
      ],
      "updated_at": "2025-02-11T13:11:58Z",
      "url": "https://www.benzinga.com/m-a/25/02/43621307/interactive-strength-to-acquire-sportstech-holding-to-acquire-99-of-sportstech-in-all-stock-transact",
      "added_at": "2025-02-11T13:15:17.369Z"
    }
  ],
  "DOMH": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-11T13:36:34Z",
      "headline": "Donald Trump Jr. And Eric Trump Join Dominari Holdings Advisory Board",
      "id": 43622581,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "DOMH"
      ],
      "updated_at": "2025-02-11T13:36:34Z",
      "url": "https://www.benzinga.com/news/25/02/43622581/donald-trump-jr-and-eric-trump-join-dominari-holdings-advisory-board",
      "added_at": "2025-02-11T14:01:06.618Z"
    },
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-11T13:35:57Z",
      "headline": "Dominari Holdings Announces $13.5M Registered Direct And Private Placement At $3.47/Share And Accompanying Warrants",
      "id": 43622570,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "DOMH"
      ],
      "updated_at": "2025-02-11T13:35:57Z",
      "url": "https://www.benzinga.com/news/25/02/43622570/dominari-holdings-announces-13-5m-registered-direct-and-private-placement-at-3-47share-and-accompany",
      "added_at": "2025-02-11T14:01:06.618Z"
    }
  ],
  "CJMB": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-11T14:01:53Z",
      "headline": "Callan JMB Has Been Awarded A Second Five-Year Contract By The Oregon Health Authority For Medical Emergency Preparedness And Response Services",
      "id": 43623682,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "CJMB"
      ],
      "updated_at": "2025-02-11T14:01:54Z",
      "url": "https://www.benzinga.com/news/25/02/43623682/callan-jmb-has-been-awarded-a-second-five-year-contract-by-the-oregon-health-authority-for-medical-e",
      "added_at": "2025-02-11T14:05:18.248Z"
    }
  ],
  "NIPG": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-11T13:32:06Z",
      "headline": "NIP Group Enters Into A Strategic Partnership With Optics Valley Traffic Company",
      "id": 43622351,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "NIPG"
      ],
      "updated_at": "2025-02-11T13:32:22Z",
      "url": "https://www.benzinga.com/news/25/02/43622351/nip-group-enters-into-a-strategic-partnership-with-optics-valley-traffic-company",
      "added_at": "2025-02-11T14:09:43.766Z"
    }
  ],
  "ORMP": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-11T14:18:28Z",
      "headline": "Oramed Announces Entered Into Definitive Agremeents To Spin Off Protein Oral Delivery Technology Into Joint Venture With Hefei Tianhui Biotech",
      "id": 43624429,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "ORMP"
      ],
      "updated_at": "2025-02-11T14:18:29Z",
      "url": "https://www.benzinga.com/general/biotech/25/02/43624429/oramed-announces-entered-into-definitive-agremeents-to-spin-off-protein-oral-delivery-technology-",
      "added_at": "2025-02-11T14:20:18.396Z"
    }
  ],
  "AIOT": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-11T12:50:03Z",
      "headline": "Northland Capital Markets Maintains Outperform on PowerFleet, Raises Price Target to $11",
      "id": 43620351,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "AIOT"
      ],
      "updated_at": "2025-02-11T12:50:04Z",
      "url": "https://www.benzinga.com/news/25/02/43620351/northland-capital-markets-maintains-outperform-on-powerfleet-raises-price-target-to-11",
      "added_at": "2025-02-11T14:39:21.095Z"
    },
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-10T16:40:59Z",
      "headline": "Barrington Research Maintains Outperform on PowerFleet, Maintains $15 Price Target",
      "id": 43599699,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "AIOT"
      ],
      "updated_at": "2025-02-10T16:41:00Z",
      "url": "https://www.benzinga.com/news/25/02/43599699/barrington-research-maintains-outperform-on-powerfleet-maintains-15-price-target",
      "added_at": "2025-02-11T14:39:21.095Z"
    },
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-11T15:48:48Z",
      "headline": "Lake Street Maintains Buy on PowerFleet, Raises Price Target to $11",
      "id": 43628959,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "AIOT"
      ],
      "updated_at": "2025-02-11T15:48:48Z",
      "url": "https://www.benzinga.com/news/25/02/43628959/lake-street-maintains-buy-on-powerfleet-raises-price-target-to-11",
      "added_at": "2025-02-11T15:50:20.225Z"
    }
  ],
  "SIDU": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-11T13:49:16Z",
      "headline": "Sidus Space Completion Integration With LizzieSat-3 Launch Vehicle At Astrotech Space Operations Facility",
      "id": 43622986,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "SIDU"
      ],
      "updated_at": "2025-02-11T13:49:16Z",
      "url": "https://www.benzinga.com/news/25/02/43622986/sidus-space-completion-integration-with-lizziesat-3-launch-vehicle-at-astrotech-space-operations-fac",
      "added_at": "2025-02-11T14:47:43.293Z"
    }
  ],
  "AIFF": [],
  "LTRY": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-11T12:48:42Z",
      "headline": "Lottery.com's Brand Sports.com Inks Multi-Year Partnership Agreement With Soccerex",
      "id": 43620340,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "LTRY"
      ],
      "updated_at": "2025-02-11T12:48:43Z",
      "url": "https://www.benzinga.com/general/entertainment/25/02/43620340/lottery-coms-brand-sports-com-inks-multi-year-partnership-agreement-with-soccerex",
      "added_at": "2025-02-11T15:26:24.258Z"
    }
  ],
  "SOPA": [
    {
      "author": "Benzinga Insights",
      "content": "",
      "created_at": "2025-02-11T17:30:27Z",
      "headline": "Peering Into Society Pass's Recent Short Interest",
      "id": 43633166,
      "images": [
        {
          "size": "large",
          "url": "https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2023/movers_image_5.jpeg"
        },
        {
          "size": "small",
          "url": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2023/movers_image_5.jpeg"
        },
        {
          "size": "thumb",
          "url": "https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2023/movers_image_5.jpeg"
        }
      ],
      "source": "benzinga",
      "summary": " ",
      "symbols": [
        "SOPA"
      ],
      "updated_at": "2025-02-11T17:30:27Z",
      "url": "https://www.benzinga.com/insights/short-sellers/25/02/43633166/peering-into-society-passs-recent-short-interest",
      "added_at": "2025-02-11T17:30:52.718Z"
    }
  ]
}